Assessing the Cost Effectiveness of an Incremental Lipid-Lowering Therapy Approach After Coronary Artery Bypass Grafting Using Nationwide Data. [PDF]
Deo SV +11 more
europepmc +1 more source
Oligogenic Familial Hypercholesterolemia Treated by Combination Therapy of Statin, Ezetimibe, PCSK9 Inhibitor, and Lomitapide. [PDF]
Kojima N, Tada H, Takamura M.
europepmc +1 more source
Modulation of oxidation-related immune markers by lipid-lowering medications in individuals with elevated lipoprotein(a). [PDF]
Koutsogianni AD +6 more
europepmc +1 more source
A multi-center, open-label, observational study to evaluate the efficacy and safety of LivaloZet<sup>®</sup> tablets in patients with dyslipidemia and metabolic syndrome: PIVOT study protocol. [PDF]
Joung KH, Ku BJ.
europepmc +1 more source
Multiple Probiotic Lactic Acid Bacteria with Marked Cholesterol-Lowering Effects Were Discovered in Equine Colostrum. [PDF]
Liu X +4 more
europepmc +1 more source
Targeting LDL Across the Whole Spectrum of Chronic Kidney Disease: From Pathophysiology to Novel Treatments. [PDF]
Minutolo R +8 more
europepmc +1 more source
Prevalence and Medical Treatment of Arterial Hypertension and Hypercholesterolemia in Germany: a Nationwide questionnaire-based Survey in Medical Practices. [PDF]
Beger C +4 more
europepmc +1 more source
PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial. [PDF]
Chen Z +9 more
europepmc +1 more source
Metabolic and Safety Outcomes of Statin-Ezetimibe Versus High-Intensity Statin in Older Patients. [PDF]
Cha JJ +12 more
europepmc +1 more source
Impact of Antihypertensive, Antihyperlipidemic, and Mixed Antidepressant Medications on Dental Implant Success: A Retrospective Cohort Study. [PDF]
Chidiac A +3 more
europepmc +1 more source

